Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Directorate Change

1 Nov 2022 07:00

RNS Number : 8197E
Aston Martin Lagonda Glob.Hldgs PLC
01 November 2022
 

1 November 2022

Aston Martin Lagonda Global Holdings plc

Appointment of Non-executive Directors and Board Committee appointments

Aston Martin Lagonda Global Holdings plc (the "Company") announces the appointment of Ahmed Al-Subaey and Frederick Robertson to the Board as representative Non-executive Directors of the Public Investment Fund, with effect from 1 November 2022. The appointments are made in accordance with the Relationship Agreement entered into between the Company and the Public Investment Fund on 29 July 2022. 

Ahmed Al-Subaey is Chief Executive Officer of Bahri, the National Shipping Company of Saudi Arabia, which is listed on the Saudi Stock Exchange. Mr Al-Subaey holds a BSC and Masters degree in electrical engineering from the University of Arizona and an executive MBA from Stanford University. 

Frederick Robertson is Senior Director and Head of Public Investments, International Investments Division at the Public Investment Fund. Mr Robertson started his career as an investment analyst having studied economics at Cornell University. Mr Robertson will be appointed as a member of the Nomination Committee and an observer to both the Audit and Risk Committee and Remuneration Committee with effect from 1 November 2022.

Lawrence Stroll, Executive Chairman of Aston Martin, said: "I am delighted to welcome Ahmed Al-Subaey and Frederick Robertson as PIF's appointed representatives to the Board. These appointments are an important part of our relationship with PIF, our second largest shareholder".

The Company confirms that there is no further information to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules of the Financial Conduct Authority with regard to either of these appointments.

The Company further announces the appointment of Sir Nigel Boardman as a member of the Nomination Committee and Audit and Risk Committee with effect from 1 November 2022. As previously announced, Sir Nigel was appointed as an independent Non-executive Director of the Company on 1 October 2022.

Enquiries

Investors and Analysts

Sherief Bakr

Director of Investor Relations

+44 (0)7789 177547sherief.bakr@astonmartin.com 

Holly Grainger

Deputy Head, Investor Relations

+44 (0)7442 989551holly.grainger@astonmartin.com 

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683kevin.watters@astonmartin.com 

Paul Garbett

Head of Corporate and Brand Communications

 

+44 (0)7501 380799paul.garbett@astonmartin.com

Grace Barnie

Corporate Communications Manager

+44 (0)7880 903490grace.barnie@astonmartin.com 

Tulchan Communications

Harry Cameron and Simon Pilkington

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGBCUUPPPUG
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.